Medical/Scientific Meetings

PAST Medical and Scientific Meetings

Staff members from the Pancreatic Cancer Action Network attend and participate in a number of medical and scientific meetings throughout the year.  On this page you will find summaries of educational information from various meetings.  This information is intended to summarize a selection of sessions. 

2010 Gastrointestinal Cancers Symposium
January 22-24, 2010
Orlando, Florida
Select Pancreatic Cancer Sessions

Detailed summaries are downloadable in pdf format.

Session IV -- Prevention, Screening and Diagnosis

The role of Octreotide Imaging in Detecting Neuroendocrine Tumors (NETs) in 2010: Do we still need it?

Session V – Translational Research

Drug Delivery in Pancreatic Cancer

 

Session VI – Multidisciplinary Treatment

Updated Results of the Phase III Trial of Sunitinib Versus Placebo for the Treatment of Advanced Pancreatic Neuroendocrine Tumors

 

Oral Abstract Session

Phase I study of MK-0646 (dalotuzumab), a Humanized Monoclonal Antibody Against IGF-1R in Combination with Gemcitabine or Gemcitabine plus Erlotinib for Advanced Previously Untreated Pancreatic Cancer

Multi-institutional Phase II Trial of Induction Cetuximab, Gemcitabine and Oxaliplatin Followed by Radiotherapy with Concurrent Capecitabine and Cetuximab for Locally Advanced Pancreatic Adenocarcinoma

 

The information and services provided by the Pancreatic Cancer Action Network, Inc. are for informational purposes only.  The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment.  If you are ill, or suspect that you are ill, see a doctor immediately!  The Pancreatic Cancer Action Network does not recommend nor endorse any specific physicians, products or treatments even though they may be mentioned on this site.  100316